Press Releases Latest Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment Press Releases Year None202420232022202120202019201820172016201520142013 Jul 11, 2013 Theratechnologies obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI Jul 10, 2013 Theratechnologies Announces Financial Results for Second Quarter of 2013 Jul 08, 2013 Request for Reconsideration in Canada: Meeting With Scientific Advisory Committee Authorized Jul 03, 2013 Theratechnologies to Announce Second Quarter 2013 Financial Results Jun 28, 2013 Theratechnologies provides regulatory update for Colombia May 27, 2013 Information on Class Action Motion May 24, 2013 Announcements in Conjunction With Theratechnologies Annual Meeting Apr 11, 2013 Theratechnologies Announces Financial Results for First Quarter of 2013 Apr 09, 2013 Theratechnologies Board of Directors Appoints Former Merck Canada President Apr 08, 2013 Theratechnologies Announces Termination of Agreement With Ferrer First page « Previous page ‹ … Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Current page 37 Page 38 Next page › Last page » Displaying 361 - 370 of 379
Dec 18, 2024 Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV® Manufacturing Environment
Jul 11, 2013 Theratechnologies obtains US Patent for Improving Cognitive Function with Tesamorelin in Patients Suffering from MCI
Jul 08, 2013 Request for Reconsideration in Canada: Meeting With Scientific Advisory Committee Authorized
